Showing results (1-10 of 264) with videos related to
Sort By:
Pageof 27
Expert Review of Anticancer Therapy|May 18, 2010
S-1 plus cisplatin: another option in the treatment of advanced head and neck cancer?Dok Hyun Yoon, Sung-Bae KimBlood Research|October 18, 2014
Serum beta-2 microglobulin in malignant lymphomas: an old but powerful prognostic factorChanghoon Yoo, Dok Hyun Yoon, Cheolwon SuhSeminars in Hematology|December 14, 2025
Targeting B-cell maturation antigen in relapsed or refractory multiple myeloma: On the verge of its prime timeJun Ho Yi, Dok Hyun Yoon, Kihyun KimAnnals of Hematology|July 16, 2015
Body mass index as a prognostic factor in Asian patients treated with chemoimmunotherapy for diffuse large B cell lymphoma, not otherwise specifiedHee Sang Hwang, Dok Hyun Yoon, Cheolwon Suh, et al.Annals of Hematology|May 12, 2016
A new extranodal scoring system based on the prognostically relevant extranodal sites in diffuse large B-cell lymphoma, not otherwise specified treated with chemoimmunotherapyHee Sang Hwang, Dok Hyun Yoon, Cheolwon Suh, et al.Annals of Hematology|April 25, 2012
Impact of the Epstein-Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in KoreaYoung Wha Koh, Dok Hyun Yoon, Cheolwon Suh, et al.International Journal of Molecular Sciences|January 25, 2018
Incorporation of Immune Checkpoint Blockade into Chimeric Antigen Receptor T Cells (CAR-Ts): Combination or Built-In CAR-TDok Hyun Yoon, Mark J Osborn, Jakub Tolar, et al.Cancer Research and Treatment|August 14, 2025
Clinicopathological Significance of Tumor-Infiltrating T Lymphocytes and Macrophages in Primary Large B-Cell Lymphoma of Immune-Privileged SitesJinseong Kim, Deokhoon Kim, Hyungwoo Cho, et al.American Journal of Clinical Pathology|March 13, 2014
CSF-1R expression in tumor-associated macrophages is associated with worse prognosis in classical Hodgkin lymphomaYoung Wha Koh, Chansik Park, Dok Hyun Yoon, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 6, 2013
MET and MST1R as prognostic factors for classical Hodgkin's lymphomaYoung Wha Koh, Chansik Park, Dok Hyun Yoon, et al.Pageof 27